Switch to: References

Add citations

You must login to add citations.
  1. The Limits of Privacy: Surveillance and the Control of Disease.Ronald Bayer & Amy Fairchild - 2002 - Health Care Analysis 10 (1):19-35.
    What justified the Center for Disease Control's1999 determination to require HIV casereporting? Why were names necessary? Why didopponents view the reporting of names with suchalarm? This paper retells the history of theencounters over HIV reporting that had occurredsince the mid 1980s. In placing HIV reportingwithin a larger context, however, we understandthe clash between privacy and public healthnecessity as a complex issue, both inhistorical and contemporary practice. Byunderscoring the similarities and differenceswith the histories of surveillance for otherinfectious diseases, vaccination, occupationaldiseases, cancer, (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • The genesis of public health ethics.Ronald Bayer & Amy L. Fairchild - 2004 - Bioethics 18 (6):473–492.
    ABSTRACT As bioethics emerged in the 1960s and 1970s and began to have enormous impacts on the practice of medicine and research – fuelled, by broad socio‐political changes that gave rise to the struggle of women, African Americans, gay men and lesbians, and the antiauthoritarian impulse that characterised the New Left in democratic capitalist societies – little attention was given to the question of the ethics of public health. This was all the more striking since the core values and practices (...)
    Download  
     
    Export citation  
     
    Bookmark   42 citations  
  • Drug Trials, Doctors, and Developing Countries: Toward a Legal Definition of Informed Consent.Adina M. Newman - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):387.
    Assume this hypothetical situation: an American pharmaceutical company, Maxwell Fisch Pharmaceuticals, Inc., wishes to perform clinical trials involving a new antipsychotic medication, Klezac. Klezac is in its third phase of the clinical stage of the drug research process. Once the testing is complete, Maxwell plans to submit a New Drug Application, the official request to begin marketing Klezac, to the Food and Drug Administration. The new drug is expected to receive FDA approval in 2 or more years. The company decides (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical review of health research: a perspective from developing country researchers.A. A. Hyder - 2004 - Journal of Medical Ethics 30 (1):68-72.
    Background: Increasing collaboration between industrialised and developing countries in human research studies has led to concerns regarding the potential exploitation of resource deprived countries. This study, commissioned by the former National Bioethics Advisory Commission of the United States, surveyed developing country researchers about their concerns and opinions regarding ethical review processes and the performance of developing country and US international review boards .Methods: Contact lists from four international organisations were used to identify and survey 670 health researchers in developing countries. (...)
    Download  
     
    Export citation  
     
    Bookmark   51 citations  
  • Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.N. Sofaer & D. Strech - 2011 - Public Health Ethics 4 (2):160-184.
    Background : researchers and sponsors increasingly confront the issue of whether participants in a clinical trial should have post-trial access (PTA) to the trial drug. Legislation and guidelines are inconsistent, ambiguous or silent about many aspects of PTA. Recent research highlights the potential importance of systematic reviews (SRs) of reason-based literatures in informing decision-making in medicine, medical research and health policy. Purpose: to systematically review reasons why drug trial participants should, or need not be ensured PTA to the trial drug (...)
    Download  
     
    Export citation  
     
    Bookmark   31 citations  
  • Operationalising a real-time research ethics approach: supporting ethical mindfulness in agriculture-nutrition-health research in Malawi.Joseph Mfutso-Bengo, Edward Joy, Eric Umar, Kate Millar & Limbanazo Matandika - 2022 - BMC Medical Ethics 23 (1):1-17.
    BackgroundThere have been notable investments in large multi-partner research programmes across the agriculture-nutrition-health (ANH) nexus. These studies often involve human participants and commonly require research ethics review. These ANH studies are complex and can raise ethical issues that need pre-field work, ethical oversight and also need an embedded process that can identify, characterise and manage ethical issues as the research work develops, as such more embedded and dynamic ethics processes are needed. This work builds on notions of ‘ethics in practice’ (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries.Amulya Mandava, Christine Pace, Benjamin Campbell, Ezekiel Emanuel & Christine Grady - 2012 - Journal of Medical Ethics 38 (6):356-365.
    Objective Some researchers claim that the quality of informed consent of clinical research participants in developing countries is worse than in developed countries. To evaluate this assumption, we reviewed the available data on the quality of consent in both settings. Methods We conducted a comprehensive PubMed search, examined bibliographies and literature reviews, and consulted with international experts on informed consent in order to identify studies published from 1966 to 2010 that used quantitative methods, surveyed participants or parents of paediatric participants (...)
    Download  
     
    Export citation  
     
    Bookmark   29 citations  
  • National Human Research Ethics: A Preliminary Comparative Case Study of Germany, Great Britain, Romania, and Sweden.Bernard Gallagher, Anne H. Berman, Justyna Bieganski, Adele D. Jones, Liliana Foca, Ben Raikes, Johanna Schiratzki, Mirjam Urban & Sara Ullman - 2016 - Ethics and Behavior 26 (7):586-606.
    Although international research is increasing in volume and importance, there remains a dearth of knowledge on similarities and differences in “national human research ethics”, that is, national ethical guidelines, Institutional Review Boards, and research stakeholder’ ethical attitudes and behaviors. We begin to address this situation by reporting upon our experiences in conducting a multinational study into the mental health of children who had a parent/carer in prison. The study was conducted in 4 countries: Germany, Great Britain, Romania, and Sweden. Data (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Is there a need or space for gene technology ethics: An Australian perspective.Don Chalmers - 2008 - In Darryl R. J. Macer (ed.), Asia-Pacific Perspectives on Biotechnology and Bioethics. Unesco Bangkok. pp. 1888.
    Download  
     
    Export citation  
     
    Bookmark